Page last updated: 2024-08-21

fluorobenzenes and Carotid Artery Diseases

fluorobenzenes has been researched along with Carotid Artery Diseases in 21 studies

Research

Studies (21)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	5 (23.81)	29.6817
2010's	15 (71.43)	24.3611
2020's	1 (4.76)	2.80

Authors

Authors	Studies
Bots, ML; Chen, Y; Fu, L; Hu, B; Hu, H; Karlson, BW; Li, H; Li, X; Li, Z; Meng, X; Nie, Z; Wang, Y; Wei, D; Zhao, B; Zheng, H	1
Hutten, BA; Kastelein, JJ; Kusters, DM; Wiegman, A	1
Diao, Y; Liu, Z; Lu, F; Qi, Z; Song, H; Wei, F; Ye, L; Zhang, H; Zhao, Y	1
Feng, X; Li, X; Liu, M; Zhang, J	1
Cai, J; Du, R; Gao, P; Leng, WX; Liu, DQ; Ma, L; Wang, QJ; Wu, HM; Ye, P; Zhao, XQ	1
Bazzano, LA; Bucciarelli, T; D'Orazio, N; di Ilio, E; Mancini, B; Riccioni, G	1
Bots, ML; Crouse, JR; Dogan, S; Evans, GW; Grobbee, DE; O'Leary, DH; Palmer, MK; Plantinga, Y; Raichlen, JS	1
Boffito, M; Collot-Teixeira, S; De Lorenzo, F; Gazzard, B; McGregor, JL; Shotliff, K; Xiao, H	1
Bots, ML; Crouse, JR; Evans, GW; Grobbee, DE; O'Leary, DH; Palmer, MK; Raichlen, JS	1
D'Orazio, N; Mancini, B; Riccioni, G; Vitulano, N; Zanasi, A	1
Lai, JP; Lam, CS; Mok, CC; To, CH; Wong, CK	1
Bots, ML; Crouse, JR; den Ruijter, HM; Evans, GW; Grobbee, DE; O'Leary, DH; Palmer, MK; Peters, SA; Raichlen, JS	2
Bucciarelli, T; Cipollone, F; D'Orazio, N; Mezzetti, A; Riccioni, G; Santovito, D; Scotti, L	1
Daida, H; Hata, M; Kaku, K; Kawamori, R; Kishimoto, J; Kurabayashi, M; Masuda, I; Nohara, R; Sakuma, I; Yamazaki, T; Yokoi, H; Yoshida, M	1
Ishihara, M	1
Pencina, MJ; Polak, JF	1
Bots, ML; Crouse, JR; den Ruijter, HM; Evans, GW; Grobbee, DE; Lind, L; O'Leary, DH; Palmer, MK; Peters, SA; Raichlen, JS	1
Al-Abri, A; Al-Dhuhli, H; Al-Hashmi, K; Al-Hinai, AT; Al-Rasadi, K; Al-Sabti, H; Al-Waili, K; Al-Yaarubi, S; Al-Zakwani, I; Banerjee, Y	1
Mikhailidis, DP; Paraskevas, KI; Wierzbicki, AS	1
Cain, VA; Chu, B; Hamar, W; Hatsukami, TS; Kraiss, LW; Liu, F; Neradilek, B; Parker, DL; Polissar, NL; Raichlen, JS; Saam, T; Takaya, N; Underhill, HR; Waterton, JC; Yuan, C; Zhao, XQ	1

Reviews

1 review(s) available for fluorobenzenes and Carotid Artery Diseases

Article	Year
[Impact on the carotid intima-medial thickness and safety of rosuvastatin in Chinese patients with carotid atherosclerosis: a meta-analysis]. Zhonghua xin xue guan bing za zhi, 2014, Volume: 42, Issue:3 Topics: Carotid Artery Diseases; Carotid Intima-Media Thickness; Female; Fluorobenzenes; Humans; Male; Pyrimidines; Rosuvastatin Calcium; Sulfonamides	2014

Trials

14 trial(s) available for fluorobenzenes and Carotid Artery Diseases

Article	Year
Rosuvastatin Slows Progression of Carotid Intima-Media Thickness: The METEOR-China Randomized Controlled Study. Stroke, 2022, Volume: 53, Issue:10 Topics: Adult; Atherosclerosis; Cardiovascular Diseases; Carotid Arteries; Carotid Artery Diseases; Carotid Intima-Media Thickness; Disease Progression; Fluorobenzenes; Humans; Lipids; Pyrimidines; Rosuvastatin Calcium; Sulfonamides	2022
Carotid intima-media thickness in children with familial hypercholesterolemia. Circulation research, 2014, Jan-17, Volume: 114, Issue:2 Topics: Adolescent; Age Factors; Biomarkers; Canada; Carotid Arteries; Carotid Artery Diseases; Carotid Intima-Media Thickness; Child; Cholesterol, LDL; Europe; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Linear Models; Logistic Models; Male; Multivariate Analysis; Predictive Value of Tests; Pyrimidines; Risk Factors; Rosuvastatin Calcium; Sex Factors; Sulfonamides; United States	2014
Treatment with telmisartan/rosuvastatin combination has a beneficial synergistic effect on ameliorating Th17/Treg functional imbalance in hypertensive patients with carotid atherosclerosis. Atherosclerosis, 2014, Volume: 233, Issue:1 Topics: Adult; Aged; Benzimidazoles; Benzoates; Carotid Arteries; Carotid Artery Diseases; Carotid Intima-Media Thickness; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Female; Fluorobenzenes; Humans; Hypertension; Male; Middle Aged; Nuclear Receptor Subfamily 1, Group F, Member 3; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; T-Lymphocytes, Regulatory; Telmisartan; Th17 Cells	2014
Early decrease in carotid plaque lipid content as assessed by magnetic resonance imaging during treatment of rosuvastatin. BMC cardiovascular disorders, 2014, Jul-14, Volume: 14 Topics: Aged; Asymptomatic Diseases; Biomarkers; Carotid Artery Diseases; Carotid Artery, Common; China; Cholesterol, LDL; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Magnetic Resonance Imaging; Male; Middle Aged; Necrosis; Plaque, Atherosclerotic; Predictive Value of Tests; Prospective Studies; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Time Factors; Treatment Outcome	2014
Intensive lipid lowering may reduce progression of carotid atherosclerosis within 12 months of treatment: the METEOR study. Journal of internal medicine, 2009, Volume: 265, Issue:6 Topics: Aged; Anticholesteremic Agents; Carotid Artery Diseases; Cholesterol, LDL; Disease Progression; Double-Blind Method; Female; Fluorobenzenes; Humans; Hypercholesterolemia; Male; Middle Aged; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Time Factors; Treatment Outcome; Tunica Intima; Ultrasonography	2009
Prevention of atherosclerosis in patients living with HIV. Vascular health and risk management, 2009, Volume: 5, Issue:1 Topics: Administration, Oral; Adult; Antiretroviral Therapy, Highly Active; Atherosclerosis; Biomarkers; C-Reactive Protein; Carotid Artery Diseases; Disease Progression; Double-Blind Method; Fluorobenzenes; HIV Infections; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Middle Aged; Pyrimidines; Research Design; Rosuvastatin Calcium; Sulfonamides; Time Factors; Treatment Outcome	2009
Does baseline carotid intima-media thickness modify the effect of rosuvastatin when compared with placebo on carotid intima-media thickness progression? The METEOR study. European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology, 2010, Volume: 17, Issue:2 Topics: Aged; Carotid Arteries; Carotid Artery Diseases; Disease Progression; Double-Blind Method; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Linear Models; Male; Middle Aged; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Time Factors; Treatment Outcome; Tunica Intima; Tunica Media; Ultrasonography	2010
One-year treatment with rosuvastatin reduces intima-media thickness in 45 hypercholesterolemic subjects with asymptomatic carotid artery disease. Pharmacology, 2010, Volume: 85, Issue:2 Topics: Atherosclerosis; Carotid Artery Diseases; Cross-Sectional Studies; Female; Fluorobenzenes; Humans; Hypercholesterolemia; Male; Middle Aged; Prospective Studies; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Time Factors; Tunica Intima; Tunica Media	2010
Effects of rosuvastatin on vascular biomarkers and carotid atherosclerosis in lupus: a randomized, double-blind, placebo-controlled trial. Arthritis care & research, 2011, Volume: 63, Issue:6 Topics: Adult; Biomarkers; C-Reactive Protein; Carotid Artery Diseases; Double-Blind Method; Female; Fluorobenzenes; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Thrombomodulin	2011
Extensive or restricted ultrasound protocols to measure carotid intima-media thickness: analysis of completeness rates and impact on observed rates of change over time. Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography, 2012, Volume: 25, Issue:1 Topics: Carotid Artery Diseases; Carotid Intima-Media Thickness; Double-Blind Method; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Longitudinal Studies; Male; Middle Aged; Placebo Effect; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome	2012
Effect of 2-year treatment with low-dose rosuvastatin on intima-media thickness in hypercholesterolemic subjects with asymptomatic carotid artery disease. Expert opinion on pharmacotherapy, 2011, Volume: 12, Issue:17 Topics: Carotid Artery Diseases; Carotid Intima-Media Thickness; Cholesterol; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Triglycerides	2011
Effect of intensive lipid-lowering therapy with rosuvastatin on progression of carotid intima-media thickness in Japanese patients: Justification for Atherosclerosis Regression Treatment (JART) study. Circulation journal : official journal of the Japanese Circulation Society, 2012, Volume: 76, Issue:1 Topics: Aged; Asian People; Carotid Artery Diseases; Carotid Intima-Media Thickness; Cholesterol, HDL; Cholesterol, LDL; Disease Progression; Female; Fluorobenzenes; Humans; Hypercholesterolemia; Hypolipidemic Agents; Japan; Longitudinal Studies; Male; Middle Aged; Pravastatin; Prospective Studies; Pyrimidines; Rosuvastatin Calcium; Single-Blind Method; Sulfonamides; Time Factors; Treatment Outcome	2012
Effect of rosuvastatin on the echolucency of the common carotid intima-media in low-risk individuals: the METEOR trial. Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography, 2012, Volume: 25, Issue:10 Topics: Carotid Artery Diseases; Carotid Intima-Media Thickness; Echocardiography; Europe; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Prevalence; Pyrimidines; Reproducibility of Results; Risk Factors; Rosuvastatin Calcium; Sensitivity and Specificity; Sulfonamides; Treatment Outcome	2012
Effect of rosuvastatin therapy on carotid plaque morphology and composition in moderately hypercholesterolemic patients: a high-resolution magnetic resonance imaging trial. American heart journal, 2008, Volume: 155, Issue:3 Topics: Aged; Carotid Arteries; Carotid Artery Diseases; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluorobenzenes; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Magnetic Resonance Imaging; Male; Middle Aged; Pyrimidines; Reproducibility of Results; Retrospective Studies; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome	2008

Other Studies

6 other study(ies) available for fluorobenzenes and Carotid Artery Diseases

Article	Year
Rosuvastatin reduces intima-media thickness in hypercholesterolemic subjects with asymptomatic carotid artery disease: the Asymptomatic Carotid Atherosclerotic Disease in Manfredonia (ACADIM) Study. Expert opinion on pharmacotherapy, 2008, Volume: 9, Issue:14 Topics: Aged; Atherosclerosis; Carotid Artery Diseases; Cholesterol, HDL; Cholesterol, LDL; Cross-Sectional Studies; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Italy; Middle Aged; Prospective Studies; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Triglycerides; Tunica Intima	2008
Intensive lipid-lowering therapy with statins for primary prevention. Circulation journal : official journal of the Japanese Circulation Society, 2012, Volume: 76, Issue:1 Topics: Asian People; Carotid Artery Diseases; Carotid Intima-Media Thickness; Disease Progression; Female; Fluorobenzenes; Humans; Hypercholesterolemia; Hypolipidemic Agents; Male; Pyrimidines; Rosuvastatin Calcium; Sulfonamides	2012
Measuring carotid artery intima-media thickness: simplicity versus complexity? Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography, 2012, Volume: 25, Issue:1 Topics: Carotid Artery Diseases; Carotid Intima-Media Thickness; Female; Fluorobenzenes; Humans; Male; Pyrimidines; Rosuvastatin Calcium; Sulfonamides	2012
Sample size requirements in trials using repeated measurements and the impact of trial design. Current medical research and opinion, 2012, Volume: 28, Issue:5 Topics: Carotid Arteries; Carotid Artery Diseases; Carotid Intima-Media Thickness; Clinical Trials as Topic; Female; Fluorobenzenes; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrimidines; Randomized Controlled Trials as Topic; Rosuvastatin Calcium; Sample Size; Sulfonamides; Time Factors	2012
First case report of familial hypercholesterolemia in an Omani family due to novel mutation in the low-density lipoprotein receptor gene. Angiology, 2013, Volume: 64, Issue:4 Topics: Achilles Tendon; Anticholesteremic Agents; Apolipoproteins B; Azetidines; Biomarkers; Blood Component Removal; Carotid Artery Diseases; Carotid Intima-Media Thickness; Child; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; DNA Mutational Analysis; Drug Combinations; Exons; Eye Diseases; Ezetimibe; Female; Fluorobenzenes; Frameshift Mutation; Genetic Predisposition to Disease; Homozygote; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Oman; Pedigree; Phenotype; Pyrimidines; Receptors, LDL; Rosuvastatin Calcium; Sequence Deletion; Sulfonamides; Treatment Outcome; Triglycerides; Xanthomatosis	2013
METEOR: aiming at the stars for asymptomatic carotid artery atherosclerosis? International journal of clinical practice, 2007, Volume: 61, Issue:8 Topics: Atherosclerosis; Carotid Artery Diseases; Clinical Trials as Topic; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrimidines; Rosuvastatin Calcium; Sulfonamides	2007